The import drug license (IDL) is issued by regulatory authorities to entities importing pharmaceuticals into a country. It ensures compliance with local laws, quality standards, and safety protocols for medicines entering the market. The IDL process involves rigorous evaluation of product documentation, manufacturing practices, and intended use, safeguarding public health by preventing substandard or unsafe medications from circulation.